Hotline:021-63534350/63534360
Home >
News >
Company News>
Deep Expertise in Pharmaceutical Excipients | Driving Formulation Innovation with galenIQ™ Isomalt
Release time:2026-08-04
Browse:100 times
To our partners across China’s pharmaceutical industry,
We’re excited to announce that the Beneo Pharma official service account is now live!
As BENEO’s dedicated information platform for pharmaceutical excipients in China, this channel is built around the real needs of the formulation industry. We’ll be sharing cutting-edge global excipient technologies, application solutions, and industry insights on an ongoing basis. Going forward, BENEO will work hand in hand with our exclusive distributor in China, Shanghai Yunhong Pharmaceutical Excipient Co., Ltd., to bring high-quality, natural functional excipient solutions to the Chinese market — combining global technical expertise with localized service capabilities to support innovative formulation development.
We warmly invite all our industry partners to follow us and explore what’s next in pharmaceutical excipients — together.
— The Beneo Pharma Operations Team
About BENEO: Global Reach, Deep Excipient Expertise

BENEO is part of the Südzucker Group, one of Europe’s largest sugar producers. Founded in 2007 through the merger of three industry pioneers, the company now serves customers in more than 80 countries, supported by a team of over 1,000 experts. With seven state-of-the-art production facilities across five countries — including Germany and Belgium — and local offices in seven countries worldwide, BENEO operates a truly global network spanning R&D, manufacturing, service, and innovation.
Drawing on years of specialized experience in pharmaceutical excipients, BENEO applies rigorous production standards and a harmonized global quality management system to deliver reliable, high-quality functional ingredients to the pharmaceutical and nutraceutical sectors. Guided by a philosophy of innovation-driven, globally connected development, BENEO integrates technical resources and industrial capabilities from around the world — ensuring products meet regional standards while precisely addressing local needs. At the same time, we actively collaborate with formulation developers and research institutions worldwide to shape the future of excipient innovation.
Spotlight Product: galenIQ™ Isomalt — a Versatile Tool for Formulation Development
galenIQ™ Isomalt is a polyol derived from sucrose sourced from sugar beets. Thanks to its favorable physicochemical profile and practical advantages, it serves as an ideal filler and binder in solid dosage forms and is widely used across a range of formulations, providing multiple levers for optimizing product performance.
✅ Six Key Benefits for Diverse Manufacturing Requirements
1.Excellent processability: Chemically stable, free-flowing, non-hygroscopic, and easy to handle, with precisely controlled particle size options to suit different production processes;
2.Enhanced product performance: Good aqueous solubility supports improved content uniformity and consistent product quality;
3.Patient-friendly profile: Sugar-free and non-cariogenic, suitable for special populations including people with diabetes; non-animal origin makes it compatible with a wide range of formulation philosophies;
4.Strong regulatory credentials: Conforms to the pharmacopoeial standards of the US, UK, EU, Japan, and other key markets; IPEC member; manufactured under GMP; registered with the China CDE (Registration Nos. F20180001450, F20190001287);
5.Broad formulation versatility: Compatible with processes such as direct compression and powder blending, and suitable for multiple dosage forms including buccal tablets, chewable tablets, and granules for direct administration;
6.Consistent, reliable quality: A globally harmonized quality system ensures batch-to-batch reproducibility, offering confidence in scale-up and commercial production.

✅ Broad Dosage Form Applicability, Opening New Doors in Formulation Design
galenIQ™ Isomalt is available in specialized grades designed to meet the specific demands of different dosage forms — balancing ease of processing with finished product performance. It has already become the excipient of choice in a number of well-established formulations.

What You’ll Gain by Following Us

As BENEO’s official information hub for pharmaceutical excipients in China, Beneo Pharma is focused on what matters to formulators. Here’s what you can expect:
✅ Detailed product knowledge: A complete breakdown of the galenIQ™ range — properties, grade selection, and real-world applications;
✅ Practical application guidance: Case-based insights to help solve excipient compatibility and processing challenges in development and production;
✅ Timely industry intelligence: Updates on regulatory trends, technology developments, and evolving market needs in the excipient space;
✅ Expert technical support: Tailored excipient recommendations and direct access to technical specialists for efficient communication.

A Strong Future — Let’s Move Forward Together

At BENEO, innovation and quality are at the heart of everything we do — and pharmaceutical excipients are a core part of that commitment. Shanghai Yunhong Pharmaceutical Excipient Co., Ltd., our exclusive agent for BENEO’s pharmaceutical and health product excipient business in China, will work alongside us to deliver premium products and expert technical support to our partners across the Chinese pharmaceutical industry, backed by a well-established local service infrastructure.
The launch of the Beneo Pharma service account represents another step in deepening our dialogue with industry partners in China. With expert content and dedicated support, we look forward to collaborating with formulation scientists and manufacturing professionals — helping turn high-quality excipients into better medicines and contributing to the continued advancement of China’s pharmaceutical sector.
Follow Beneo Pharma for expert excipient content every week. We look forward to having you with us.